Skandinaviska Enskilda Banken (SEB)’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-390,505
Closed -$30.9M 271
2025
Q4
$30.9M Sell
390,505
-964,780
-71% -$75.6M 0.12% 139
2025
Q3
$108M Sell
1,355,285
-277,619
-17% -$23.7M 0.43% 45
2025
Q2
$148M Sell
1,632,904
-150,332
-8% -$13.7M 0.65% 22
2025
Q1
$167M Sell
1,783,236
-284,674
-14% -$25.5M 0.82% 23
2024
Q4
$188M Sell
2,067,910
-343,908
-14% -$32.8M 0.85% 19
2024
Q3
$250M Buy
2,411,818
+523,574
+28% +$53.4M 1.15% 16
2024
Q2
$183M Sell
1,888,244
-30,666
-2% -$2.83M 0.88% 21
2024
Q1
$173M Buy
1,918,910
+149,158
+8% +$12.6M 0.85% 19
2023
Q4
$141M Buy
1,769,752
+382,408
+28% +$28.8M 0.82% 21
2023
Q3
$98.7M Buy
1,387,344
+281,627
+25% +$21.1M 0.65% 28
2023
Q2
$85.2M Buy
1,105,717
+128,410
+13% +$9.94M 0.56% 31
2023
Q1
$73.4M Buy
977,307
+27,358
+3% +$2.03M 0.51% 40
2022
Q4
$74.8M Sell
949,949
-110,805
-10% -$8.31M 0.56% 34
2022
Q3
$74.5M Sell
1,060,754
-74,573
-7% -$5.85M 0.57% 39
2022
Q2
$91M Buy
1,135,327
+195,604
+21% +$15.3M 0.67% 27
2022
Q1
$71.3M Buy
939,723
+219,817
+31% +$17.4M 0.42% 53
2021
Q4
$60.9M Sell
719,906
-619,863
-46% -$48.4M 0.31% 68
2021
Q3
$101M Buy
1,339,769
+45,033
+3% +$3.58M 0.56% 35
2021
Q2
$105M Buy
1,294,736
+196,939
+18% +$16.1M 0.65% 25
2021
Q1
$86.5M Buy
1,097,797
+491,273
+81% +$38.5M 0.57% 34
2020
Q4
$51.9M Buy
606,524
+311,981
+106% +$25.8M 0.36% 67
2020
Q3
$22.7M Buy
294,543
+88,119
+43% +$6.72M 0.17% 128
2020
Q2
$15.1M Sell
206,424
-105,249
-34% -$7.48M 0.12% 159
2020
Q1
$20.7M Buy
311,673
+17,699
+6% +$1.25M 0.21% 98
2019
Q4
$20.2M Buy
293,974
+26,440
+10% +$1.8M 0.16% 128
2019
Q3
$19.7M Buy
267,534
+132,678
+98% +$9.63M 0.17% 118
2019
Q2
$9.67M Sell
134,856
-988
-0.7% -$70.1K 0.08% 212
2019
Q1
$9.31M Sell
135,844
-13,207
-9% -$853K 0.09% 197
2018
Q4
$8.87M Buy
149,051
+8,547
+6% +$535K 0.08% 187
2018
Q3
$9.41M Sell
140,504
-10,600
-7% -$706K 0.07% 199
2018
Q2
$9.79M Buy
151,104
+53,758
+55% +$3.52M 0.08% 180
2018
Q1
$6.98M Sell
97,346
-57,016
-37% -$4.1M 0.07% 185
2017
Q4
$11.6M Buy
154,362
+9,715
+7% +$709K 0.1% 166
2017
Q3
$10.5M Buy
144,647
+1,300
+0.9% +$93.7K 0.1% 181
2017
Q2
$10.6M Sell
143,347
-844
-0.6% -$62.7K 0.1% 185
2017
Q1
$10.6M Buy
144,191
+2,749
+2% +$192K 0.11% 179
2016
Q4
$9.26M Sell
141,442
-1,401
-1% -$96.1K 0.11% 153
2016
Q3
$10.6M Buy
142,843
+2,311
+2% +$171K 0.11% 144
2016
Q2
$10.3M Buy
140,532
+4,198
+3% +$299K 0.12% 141
2016
Q1
$9.63M Sell
136,334
-3,890
-3% -$259K 0.11% 147
2015
Q4
$9.34M Buy
+140,224
New +$9.33M 0.12% 129

Other funds holding CL

Skandinaviska Enskilda Banken (SEB)'s CL Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 390,505 shares — an estimated $30.9M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in CL in Q4 2015 and held it in 41 quarters. The position peaked at $250M in Q3 2024. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 390,505 Colgate-Palmolive shares in Q1 2026, an estimated $30.9M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Colgate-Palmolive in Q4 2015 and held it in 41 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Colgate-Palmolive position peaked at $250M in Q3 2024.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.